BioLamina

BioLamina offers an expansive portfolio of human recombinant laminin proteins for a variety of applications. With their cell therapy grade products, they can support scientists throughout their cell therapy development process – from concept to commercialized therapy. Their Biolaminin substrates are defined, full-length laminin cell culture matrices that can be used for a variety of applications. For example, these are used for the expansion of human pluripotent stem cells and differentiation and maintenance of different specialized cell types, such as hepatocytes, cardiomyocytes, and neural cells. BioLamina is a Swedish biotechnology company with a global presence and their laminin technology has been scientifically validated in many high impact journals.

Bio-Connect supplies all BioLamina products in the Benelux. If you have any questions, please contact the helpdesk.

BioLamina products

Cat. No.DescriptionAmount
CT521-0501Biolaminin 521 CTG500 ug
MX521-0501Biolaminin 521 MX500 ug
LN521-02Biolaminin 521 LN100 ug
LN511-0202Biolaminin 511 LN100 ug
LN421-02Biolaminin 421 LN100 ug
LN411-02Biolaminin 411 LN100 ug
LN332-0202Biolaminin 332 LN100 ug
LN221-02Biolaminin 221 LN100 ug
LN211-02Biolaminin 211 LN100 ug
LN121-02Biolaminin 121 LN100 ug
LN111-02Biolaminin 111 LN100 ug
LNKT-0201LAMscreen400 ug
BS521-0101Biosilk 521752 ug
BS-0101Biosilk750 ug

Major product lines

  • Defined and xeno-free laminin-based cell culture matrices
    - Animal stem cells
    - Cancer cells
    - Cardiac applications
    - Clonal applications
    - Endothelial applications
    - Epithelial applications
    - Expansion of human PSC
    - Eye applications
    - Hepatic applications
    - Intestinal applications
    - Kidney cell culture
    - Lung applications
    - Neural applications
    - Pancreatic applications
    - Skeletal muscle applications

BioLamina news

For more information, please visit: www.biolamina.com